• sodium
  • Ceftriaxone sodium has also been used successfully in a limited number of cases of meningitis and shunt infection caused by Staphylococcus epidermidis and Escherichia coli , however, the efficacy for these organisms in this organ system were studied in fewer than ten infections. (drugs.com)
  • Although ceftriaxone sodium has been shown to have been as effective as cefazolin in the prevention of infection following coronary artery bypass surgery, no placebo-controlled trials have been conducted to evaluate any cephalosporin antibacterial in the prevention of infection following coronary artery bypass surgery. (drugs.com)
  • vials
  • Ringer's solution or Hartmann's solution), should not be used to reconstitute ceftriaxone vials or to further dilute a reconstituted vial for IV administration because a precipitate can form. (drugs.com)
  • efficacy
  • This study highlights the efficacy, patient satisfaction, cost effectiveness, and safety of the OPAT clinic service for the treatment of acute tonsillopharyngitis with ceftriaxone. (dovepress.com)
  • According to the package insert, clinical studies did not show differences in efficacy and safety of ceftriaxone in geriatrics compared to younger patients but "greater sensitivity of some older individuals cannot be ruled out. (wikipedia.org)
  • patient
  • This study showed that the management of acute tonsillopharyngitis with ceftriaxone in the OPAT clinic is safe, clinically effective, and cost effective, with low rates of complications/readmissions and high levels of patient satisfaction. (dovepress.com)
  • acute
  • Renal stone formation with ceftriaxone therapy can result in postrenal acute renal failure in children. (aappublications.org)
  • A retrospective case notes review was conducted for all patients admitted to the OPAT clinic in the BDF-RMS with acute tonsillopharyngitis treated with ceftriaxone, between March 2012 and March 2014. (dovepress.com)
  • In the period between March 2012 and March 2014, 97 patients with acute tonsillopharyngitis were treated with ceftriaxone for a minimum of 3 days at the OPAT clinic. (dovepress.com)
  • administration
  • Additionally, calcium-containing solutions or products must not be administered within 48-hours of the last administration of ceftriaxone. (drugs.com)
  • The average time of ceftriaxone administration before PARF was 5.2 days. (aappublications.org)
  • Between January 1, 2003 and June 30, 2012, of the 127 PARF children admitted to the Pediatric Surgery Department of Tongji Hospital, there were 31 children who had a history of ceftriaxone administration a few days before PARF. (aappublications.org)
  • Ceftriaxone is approved by the U.S. Food and Drug Administration (FDA) for treating bacterial infections but not for treating ALS. (clinicaltrials.gov)
  • Although generally well tolerated, the most common adverse reactions associated with ceftriaxone are changes in white blood cell counts, local reactions at site of administration, rash, and diarrhea. (wikipedia.org)
  • It is reversed when ceftriaxone administration is stopped. (wikipedia.org)
  • reactions
  • Cases of fatal reactions with calcium-ceftriaxone precipitates in the lungs and kidneys in both term and premature neonates were reported. (drugs.com)